Development of the ECDC Testing Guidance for hepatitis B, hepatitis C and HIV

Development of the ECDC Testing Guidance for Hepatitis B, Hepatitis C and HIV

Project Period

2016-2018

Summary

In 2016, the European Centre for Disease Prevention and Control (ECDC) commissioned an update to the ECDC guidance on HIV testing: increasing uptake and effectiveness in the European Union published in December 2010 which HIV in Europe was contracted to do. The project runs over three years (2016-2018) and the aim of the update is to develop an evidence-based public health guidance to provide EU/EEA countries with an evidence-based framework to support the further development of integrated national HBV, HCV, and HIV testing policies in the EU/EEA.

This work is conducted in a consortium with PHE, SSAT and EATG and draws on a previous the evaluation conducted in 2015-2016.

The final guidance was published in November 2018 and can be accessed here.

Main Partners

L Combs, S Finne Jakobsen, D Raben, CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
I Veldhuijzen, Dutch National Institute for Public Health and the Environment (RIVM), Netherlands
M Dutarte, European AIDS Treatment Group, Brussels, Belgium
A Amato, European Centre for Disease Prevention and Control, Stockholm, Sweden
Y Yazdanpanah, INSERM, Paris, France
A van Ahee, E Bunge, L Mason, Pallas Health Research and Consultancy, Rotterdam, Netherlands
S Croxford, V Delpech, S Desai, Public Health England, London, United Kingdom
C Rae, M Rayment, A Sullivan, St. Stephen’s AIDS Trust, London, United Kingdom

COORDINATION SECRETARIAT

Rigshospitalet, University of Copenhagen
CHIP, Section 2100 Blegdamsvej 9 2100 Copenhagen Ø, Denmark

+45 35 45 57 57

eurotest@regionh.dk

POLICY SECRETARIAT

Ann Isabelle von Lingen,
Policy Officer European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13 B-1050 Brussels, Belgium

+32 2 626 96 41

annisabelle.vonlingen@eatg.org